SCHEMBL10179288

SCHEMBL10179288

CCN(CC)C(=O)c1cccc(-c2ccc3ncc(N4CCCCC4)nc3c2)c1.COCc1cccc(-c2ccc3ncc(N4CCCCC4)nc3c2)c1.O=C(Nc1ccccc1)c1ccc(-c2ccc3ncc(N4CCCCC4)nc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 3/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ NR1H4 Q96RI1 1/20 0.41
▸ SIRT2 Q8IXJ6 3/20 0.39
▸ SIRT1 Q96EB6 3/20 0.39
▸ SIRT3 Q9NTG7 2/20 0.39
▸ HCRTR1 O43613 1/20 0.39
▸ HCRTR2 O43614 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TRPV1 Q8NER1 2/20 0.39
▸ MAPT P10636 3/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13277010 0.82 HPGD (0.47) HPGDALDH1A1LMNATSHRMAPT
SCHEMBL1442220 0.82 KMT2A (0.51) MCHR1HTR2CSIRT2ALDH1A1TRPV1
SCHEMBL12811787 0.82 HTR2C (0.51) MCHR1HTR2CHPGDALDH1A1LMNA
SCHEMBL12811792 0.79 HCRTR1 (0.51) HCRTR1HCRTR2ALDH1A1MAPTSMN1; SMN2
SCHEMBL12811795 0.74 JAK2 (0.52) NR1H4HCRTR1HCRTR2ALDH1A1LMNA
SCHEMBL1442554 0.74 LRRK2 (0.47) HPGDALDH1A1LMNATSHRKMT2A
SCHEMBL1442507 0.74 EGFR (0.50) NR1H4ALDH1A1LMNATP53SMN1; SMN2
SCHEMBL12812454 0.74 HPGD (0.53) HPGDALDH1A1MAPTSMN1; SMN2
SCHEMBL13276227 0.74 PDE10A (0.44) HPGDCYP3A4SMN1; SMN2
SCHEMBL12812024 0.73 NPC1 (0.57) ALDH1A1LMNAMAPTKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473498-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS Bayer Pharma Aktiengesellschaft (DE) 2012-07-11 — — EP claimed
Send feedback